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ABSTRACT  
 
Intellectual disability (ID) is the term used to describe a diverse group of 
neurological conditions with congenital or juvenile onset, characterized by an IQ score 
of less than 70 and difficulties associated with limitations in cognitive function and 
adaptive behavior. The condition can be inherited or caused by environmental factors. 
The genetic forms are heterogeneous, with mutations in over 500 known genes shown 
to cause the disorder. We report a consanguineous Omani family in which multiple 
individuals have ID and developmental delay together with some variably present 
features including short stature, microcephaly, moderate facial dysmorphism and 
congenital malformations of the toes or hands. Homozygosity mapping combined with 
whole exome next generation sequencing identified a novel homozygous single base 
pair deletion in TUSC3, c.222delA, p.R74fs. The mutation segregates with the disease 
phenotype in a recessive manner and is absent in 60,706 unrelated individuals from 
various disease-specific and population genetic studies. TUSC3 mutations have been 
previously identified as causing either syndromic or non-syndromic ID in patients from 
France, Italy, Iran and Pakistan. This paper supports the previous clinical descriptions 
of the condition caused by TUSC3 mutations and describes the seventh family with 
mutations in this gene, thus contributing to the genetic spectrum of mutations. This is 
the first report of a family from the Arabian peninsula with this form of ID.  
 
 
 
 
 
 
 
Keywords: Intellectual disability; exome sequencing; TUSC3. 
 
 
Running title: TUSC3 mutation causes ID in Omani family 
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INTRODUCTION 
 
Intellectual disability (ID), previously called mental retardation, is an early-onset 
neurodevelopmental disorder that impacts on daily living skills. An affected individual 
struggles with memory, problem solving, language and visual comprehension as well 
as daily living skills such as self-care, independence and interpersonal communication. 
These deficits are reflected by an IQ (intelligence quotient) score of less than 70 
[Salvador-Carulla et al., 2011; American Psychiatric Association, 2014]. ID affects 1 
to 3% of the general population [Leonard and Wen, 2002] and can be caused by 
genetic or environmental factors. Environmental causes include problems with 
pregnancy or childbirth, post-natal toxicity, malnutrition, infection or injury. There is 
considerable genetic heterogeneity underlying familial ID (syndromic or not) 
[Najmabadi et al., 2011]. Chromosomal abnormalities can account for up to 15% of 
these cases [Miller et al., 2010]. There are also over 500 genes that have been linked 
to ID [Sun et al., 2015] including genes with de novo mutations in isolated cases 
[Hamdan et al., 2014]. The proteins that are disrupted in ID consist of components of 
the neuronal synaptic complex as well as molecules involved in vesicle trafficking and 
exocytosis, cell-cell and cell-matrix interactions, glutamate receptors and their 
downstream effectors, the Rho and ERK/MAPK pathways, zinc finger transcription 
factors and chromatin remodelling [Kaufman et al., 2010].  
 
In this report, we describe clinical features and molecular analysis in a 
consanguineous Omani family with multiple affected members that have ID with 
developmental delay caused by a novel TUSC3 homozygous mutation. Biallelic 
TUSC3 mutations have previously been shown to cause both non-syndromic and 
syndromic ID [Garshasbi et al., 2008; Molinari et al., 2008; Garshasbi et al., 2011; 
Khan et al., 2011; Loddo et al., 2013; El Chehadeh et al., 2015]. These findings support 
a presumed role of normal TUSC3 in the glycosylation of neurodevelopmental proteins 
[Kelleher and Gilmore, 2006; Mohorko et al., 2014].  
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MATERIALS AND METHODS 
 
The family was contacted and ascertained through the Genetic and 
Developmental Medicine Clinic at the Sultan Qaboos University Hospital, Muscat, 
Oman. This study was approved by the Sultan Qaboos University Ethical Committee. 
The affected individuals were recruited to the study with the informed consent of their 
parents using a process that adhered to the tenets of the Declaration of Helsinki. 
Peripheral blood was sampled from each individual by venipunture for genomic DNA 
extraction by the Qiagen spin column method (Qiagen Ltd., Manchester, UK) 
according to standard procedures. Ethnically-matched Omani controls were recruited 
from students of the Leeds Omani Society, using a process approved by the Leeds 
Central Research Ethics Committee (reference number 08/H1313/17). Control DNAs 
were sampled using Oragene saliva collection tubes (DNA Genotek Inc., Ontario, 
Canada) and genomic DNA was extracted using the manufacturers protocol. Array 
comparative genomic hybridization (array-CGH) was performed using the Agilent 
Human Genome CGH 105A arrays according to the suppliers instructions (Agilent 
Technologies Limited, Wokingham, UK). Whole-genome homozygosity mapping was 
performed using Affymetrix SNP 6.0 arrays (AROS Biotechnologies Ltd., Aarhus, 
Denmark) and the data analyzed and presented using AgileMultiIdeogram software 
(http://dna.leeds.ac.uk/autozygosity/). Whole exome next generation sequencing was 
carried out using the SureSelect Target Enrichment V.4 reagent (Agilent Technologies 
Limited) for library preparation, followed by deep sequencing using paired end reads 
on an Illumina HiSeq 2500 (Illumina Incorporation, Little Chesterford, UK) according 
to the manufacturers protocols. The sequencing reads were aligned to the human 
genome reference hg19 using Bowtie2 software and processed in the SAM/BAM 
format using Picard and the Genome Analysis Toolkit. Annovar software 
(http://www.openbioinformatics.org/annovar/) was used to annotate the variants. To 
check for homozygous regions in the exome data, the sequence variant list was 
analysed using AgileVariantMapper and presented as a multi-Ideogram as described 
above (http://dna.leeds.ac.uk/autozygosity/). In looking for pathogenic variants of 
disease significance, any variants with a read depth of less than 10 were excluded, as 
were variants lying outside the exons and flanking splice site regions, synonymous 
variants, variants with a minor allele frequency >1% in the exome variant server or 
1000 genomes databases as well as heterozygous variants. For PCR and Sanger 
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sequencing, oligonucleotide primers were designed with Primer3 
(http://primer3.ut.ee/). PCR was performed on genomic DNA through thermal cycling 
with an initial denaturing step of 95°C for 2 minutes then 35 cycles of 94°C for 30 
seconds (denaturing), 65°C for 30 seconds (annealing) and 72°C for 45 seconds 
(extension) followed by a final extension step of 72°C for 5 minutes. The products were 
treated with ExoSAP-IT (GE Healthcare, Freiburg, Germany) and sequenced using 
the BigDye terminator v.1.1 cycle sequencing kit (Applied Biosystems, Darmstadt, 
Germany) on an ABI3130xl Genetic Analyzer (Applied Biosystems). Results were 
analyzed using Sequence Analysis v.5.2 software (Applied Biosystems). 
 
 
RESULTS 
 
Clinical Features 
There were 4 patients with ID as the consensus feature that were identified in 
the pedigree (Figure 1 and Table I). Patient V.5, a male, was initially referred to the 
clinic at 7 years old for short stature (below the 3rd centile) and developmental delay 
of language and motor skills. In school, V.5 has difficulties with reading and writing. 
The patient also had a myopathic elongated face with a pointed chin, downslanting 
palpebral fissures, apparent hypertelorism, a downturned mouth with thin lips as well 
as very thin nails and bilateral 2-3 syndactyly of the toes. In view of the childs features 
which are reminiscent of Smith-Lemli-Opitz syndrome, 7-dehydrocholesterol was 
tested and found to be within normal limits. Further investigations including 
chromatography of plasma amino acids, urine organic acids, lactate, ammonia and 
creatinine kinase were all within normal reference ranges. Magnetic resonance 
imaging (MRI) of the brain was normal. His behavior included a fascination with the 
sight and sound of water. Family history revealed that his deceased older brother (V.I) 
also had similar clinical features as well as camptodactyly of the right fingers which 
were confirmed by reading his hospital notes and reviewing family pictures. He had 
also been assessed by the developmental team and was found to fulfil the DSM-5 
diagnostic criteria for autism spectrum disorder (ASD). Patient V.I drowned in water at 
the age of 10. Patients V.8 and V.9, a female and male respectively, share a similar 
developmental and clinical profile as patient V.5 and his deceased brother (see Table 
I), though patient V.9 does not have any congenital malformations of the hands or toes. 
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Patient V.8 has shown some delay of motor functions including problems with balance 
and a poor hand grip and was unable to hold a pencil between the thumb and finger, 
resulting in her being unable to draw a circle or a straight line. She has had difficulty 
chewing food and swallowing, and sometimes drools when performing a focused task. 
Her communication comprises a few single words, vowel sounds and non-verbal 
gestures including pointing and facial expressions. It is worth highlighting that the 
unaffected female sibling V.10 also appears to have some of the facial features 
described in the affected patients, so the mild dysmorphic features described in this 
pedigree may not be disease-specific.    
 
Molecular Analysis 
In order to determine whether a chromosomal rearrangement was the cause of 
ID, comparative genome hybridization (array-CGH) was performed in V.5, who 
showed no chromosomal rearrangement. To locate the pathogenic mutation in this 
family, genomic DNA from V.8 and V.9 was initially analyzed. These individuals have 
similar manifestations to their affected cousins V.1 and V.5, and so are likely to harbor 
the same causative genetic mutation. Analysis of DNA from V.8 by homozygosity 
mapping highlighted several regions, any of which could harbor the causative mutation 
(Figure 2A). These included regions on chromosomes 2, 3, 5, 7, 8, 10, 13, 14 and 19. 
To identify the mutation, whole exome next generation sequencing was performed on 
V.9. An initial list of 61,905 variants was used to check for homozygous regions. 
Combining the single nucleotide polymorphism data of V.8 with the whole exome 
sequencing data from V.9 highlighted a single ~11.5Mb homozygous region on 
chromosome 8 common to both affected individuals. To look for the pathogenic 
mutation, the initial variant list was reduced to 113 following variant filtration, and this 
was further reduced by excluding those variants that lay outside the common 
homozygous region on chromosome 8. This left only one candidate, a novel variant in 
TUSC3 (tumor suppressor candidate 3) [MIM 610385] which is a known ID gene. 
Sanger sequencing confirmed the presence of this single base deletion, which causes 
a frameshift mutation (NM_006765/NM_178234:c.222delA:p.R74fs) (Figure 2B). This 
mutation segregated in all the affected cases in the family as expected for recessive 
inheritance. The mutation was absent from 60,706 subjects on the ExAc database 
(http://exac.broadinstitute.org/, February 2015), and was also not present in 50 
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ethnically matched Omani control DNAs, providing further support as to the scarcity of 
this allele in the human population. 
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DISCUSSION 
 
TUSC3, also known as N33 or OST3A (oligosaccharyl transferase 3 homolog 
A), encodes a 348 amino acid protein containing a signal peptide, membrane 
anchored thioredoxin fold and four transmembrane domains. The protein is localised 
to the endoplasmic reticulum, where it forms part of the multimeric oligosaccharyl 
transferase complex that is likely to be involved in post-translational glycosylation of 
selected proteins which are essential for normal brain development [Kelleher and 
Gilmore, 2006; Mohorko et al., 2014]. It has been suggested that TUSC3 may be a 
magnesium transporter [Zhou and Clapham, 2009], though the results of that study 
could also be explained by the ability of TUSC3 to modulate the glycosylation 
efficiency of such a membrane transporter. It has also previously been observed that 
the chromosome 8p22 genomic region containing TUSC3 is frequently deleted in 
somatic cells in prostate [Bergerheim et al., 1991] and ovarian cancers [Pribill et al., 
2001]. Furthermore, silencing TUSC3 in ovarian cancer cell lines enhanced 
proliferation and migration, suggesting that the protein may be a tumour suppressor 
[VaĖhara et al., 2013]. The affected patients described in this study have not 
developed tumors, but all are relatively young and it may be appropriate to monitor for 
increased tumor risk in the future.   
 
Here we describe a novel null mutation in TUSC3 causing ID with dysmorphic 
features in a consanguineous family from Oman. This is the seventh family that has 
been identified with TUSC3 mutations causing syndromic or non-syndromic ID (Figure 
2C). Previous reports have identified a premature stop codon mutation [Garshasbi et 
al., 2011], frameshift insertion [Molinari et al., 2008], gross deletion [Garshasbi et al., 
2008; Khan et al., 2011; Loddo et al., 2013] and an intragenic duplication [El Chehadeh 
et al., 2015], all of which would be expected to produce no functional TUSC3 protein 
product. The mutation reported herein is a frameshift mutation in exon 2, which may 
lead to nonsense mediated decay of the RNA transcript, or may give rise to a truncated, 
non-functional protein. It is interesting to note that primary fibroblast cell cultures 
derived from patients with a null homozygous mutation and controls showed no 
significant differences in glycosylation of selected proteins suggesting that TUSC3 
may not have a major role in the glycosylation of extracerebral proteins [El Chehadeh 
et al., 2015]. Given the spectrum of TUSC3 mutations observed in ID cases and 
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families, it seems likely that the condition is caused by lack of functional TUSC3 protein 
during neurodevelopment rather than build-up or activity of defective mutated protein.  
 
Previous reports [Garshasbi et al., 2008; Molinari et al., 2008; Garshasbi et al., 
2011; Khan et al., 2011; Loddo et al., 2013; El Chehadeh et al., 2015] have shown 
that patients with biallelic TUSC3 mutations have moderate to severe ID with speech 
delay as the prominent features. These findings are consistent with the patients 
described in this report. Additional characteristics observed in some of the reported 
cases included short stature, microcephaly and moderate facial dysmorphism, and 
these signs were also present in some of our patients. It is worth highlighting that three 
of the four patients studied here also had congenital malformations of the toes or 
hands, which have been seen before in a single patient who also had unilateral 
cryptorchidism [Loddo et al., 2013]. Overall, there appears to be no obvious genotype-
phenotype correlation between type of mutation and the presence of additional 
features [El Chehadeh et al., 2015].  
 
This is the first time that mutations in this gene have been described in the Arab 
population. The family could be expected to benefit from this knowledge through 
genetic counselling and also through carrier screening of additional family members 
and/or potential marriage partners. Omani genetic services, which are government 
funded, have been developed and improved significantly within the healthcare system 
over the last 10 years [Rajab et al., 2013]. This coincided with a growing understanding 
of the increased burden of recessive conditions and congenital abnormalities due to 
consanguinity, with over 50% of marriages in this population being consanguineous 
[Rajab and Patton, 2000; Rajab et al., 2013]. Although consanguinity is rooted in the 
culture and reflects the preservation of traditions, religion and tribal groups, genetic 
health education and the culturally-sensitive implementation of technologies such as 
prenatal screening and pre-implantation genetic diagnosis may offer some hope for 
the family described in this report. 
 
To summarize, we have identified a novel TUSC3 mutation in a 
consanguineous family from Oman. Our findings contribute further data on the 
spectrum of mutations causing this form of ID and the phenotype associated with them. 
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LEGENDS 
 
Figure 1. Family pedigree of Omani family with affected members that have ID with 
developmental delay. 
 
Figure 2. Molecular analysis. 
(A) AgileMultiIdeogram representation of the homozygosity mapping data using 
GRCh38 reference assembly. The homozygous regions in the SNP data from subject 
V.8 (outer circle) and the WES data from subject V.9 (inner circle) are highlighted (in 
pink). A common homozygous region (in blue) on chromosome 8 (6,420,534-
17,915,526) is shown. TUSC3 maps to chromosome 8 at 15,540,087  15,766,649. 
(B) Sanger sequencing chromatograms depicting the one base pair deletion mutation, 
c.222delA, in an affected individual from the family and a normal control subject for 
comparison. 
(C) Diagram showing TUSC3 mutations that have been identified to date mapped onto 
the GRCh38 reference genomic DNA sequence, with exons highlighted according to 
the transcript with accession code, NM_006765.3. n denotes the number of patients 
with that mutation. So far a total of 25 patients have been described with TUSC3 
mutations. The superscript notation assigns the reference that reports the mutation as 
follows: 1. Molinari et al, 2008; 2. Garshasbi et al, 2008; 3. Khan et al, 2011; 4. 
Garshasbi et al, 2011; 5. Loddo et al, 2013; 6. El Chehadeh et al, 2015 and #  
represents the mutation reported in the current study.  
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Table I. Summary of clinical features in affected cases from the studied Omani 
family. 
 
ID (Gender) V.1 (M) V.5 (M) V.8 (F) V.9 (M)  V.10 (F) 
TUSC3 
genotype 
(status) 
M/M   
(affected) 
M/M 
(affected) 
M/M 
(affected) 
M/M 
(affected)  
M/+ 
(unaffected)
Growth 
parameters (at 
birth) 
Wt = 50th centile 
Ht = 10th centile 
HC = 25th centile 
Wt = 3rd centile 
Ht = 10th centile 
HC = 3rd centile 
Wt = 3rd centile 
Ht = <3rd centile 
HC = <3rd centile 
Wt = 3rd centile 
Ht = <3rd centile 
HC = <3rd centile 
 
Wt = 90th centile 
Ht = 50th centile 
HC = 50th centile 
Congenital 
malformations 
Unilateral 
camptodactyly 
- hand 
Bilateral 2-3 
syndactyly 
- toes 
Bilateral 2-3 
syndactyly 
- toes 
-  - 
Growth 
parameters 
(age) 
Wt = 3rd centile 
Ht = <3rd centile 
HC = 3rd centile 
(9 years) 
Wt = <3rd centile 
Ht = <3rd centile 
HC = 3rd centile 
(7 years) 
Wt = 50th centile 
Ht = 10th centile 
HC = 25th centile 
(3 years) 
Wt = 3rd centile 
Ht = <3rd centile 
HC = <3rd centile 
(1 year) 
 
Wt = 3rd centile 
Ht = 10th centile 
HC = 50th centile 
(5 years) 
Facial features 
Hypertelorism 
Long face 
Deep set eyes 
Thin philtrum 
Pointed chin 
Hypertelorism 
Long face 
Thin philtrum 
Pointed chin 
Hypertelorism 
Hypertelorism 
Thin philtrum 
 
Hypertelorism 
Thin philtrum 
Brain imaging N/R Normal MRI N/R N/R  Normal MRI
IQ N/R 53 40 50  81 
Autism 
spectrum 
disorder 
+ - - -  + 
Developmental 
profile N/R 
Motor and 
language skills 
delayed 
Poor reading and 
writing ability 
Motor and 
language skills 
delayed 
Walked at 20 
months 
Can say ~5 words 
with meaning at 1 
year 
 
Walked at 19 
months 
Single words at 
2.5 years 
Current language 
normal but has 
delayed 
echolalia; also 
has hyperlaxia
Growth parameters were measured using the World Health Organisation child growth 
standards and IQ was measured using the Stanford Binet intelligence test (5th edition). 
N/R = not recorded, + = 
